SGI
RIGL icon

Summit Global Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Summit Global Investments’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,060
Closed -$801K – 597
2021
Q3 		$801K Sell
22,060
-310
-1% -$12.2K 0.06% 243
2021
Q2 		$971K Buy
+22,370
New +$845K 0.06% 236

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Summit Global Investments's RIGL Position: Q4 2021 in Review

Summit Global Investments sold out of Rigel Pharmaceuticals (RIGL) in Q4 2021, closing a stake of 22,060 shares — an estimated $801K sold.

Summit Global Investments first reported a position in RIGL in Q2 2021 and held it in 2 quarters. The position peaked at $971K in Q2 2021. 162 funds tracked by Wall St. Rank hold RIGL as of Q4 2021.

  • Summit Global Investments reported no remaining Rigel Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 22,060 Rigel Pharmaceuticals shares in Q4 2021, an estimated $801K.
  • Summit Global Investments first reported a position in Rigel Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Summit Global Investments's Rigel Pharmaceuticals position peaked at $971K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.